Quick Asked: Triplet Therapeutics Contact Us?
Last update: 23 Apr, 2024 
400 Views
What is tritriplet therapeutics? Triplet Therapeutics is an early stage start-up biotherapeutics company developing new therapeutic approaches to address triplet repeat disorders such as Huntington’s disease and Myotonic Dystrophy. There are approximately 40 known triple repeat disorders that devastate the lives of people and their families with no known treatment options to date.What is triplets patient support fund? Triplet is committing 1% of its company value into an independently managed patient support fund that will be used to secure access to care and therapies. Triplet was founded at the nexus of a new genetic understanding of repeat expansion disorders.Who is the new president of therapeuticsmd? BOCA RATON, Fla., August 09, 2021--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced the appointment of Hugh O’Dowd as President. Mr. O’Dowd succeeds John C.K. Milligan, IV, who the Company recently appointed as Chief Executive Officer of its vitaCare Prescription Services business.
Listing Results Triplet Therapeutics Contact Us? Question Answers
Triplet Therapeutics Company Profile: Valuation
+1 (781) 000-0000 One Kendall Square, 1400 West Suite 14201 Cambridge, MA 02139 United States +1 (781) 000-0000 Triplet Therapeutics Timeline 2019 2020 2021 Financing Round Captured Employee Count Estimated Employee Growth Want detailed data on 3M+ companies? What you see here scratches the surface Request a free trial Looking for startup resources?
Triplet Therapeutics MassBio
OUR FOCUS Triplet Therapeutics is an early stage start-up biotherapeutics company developing new therapeutic approaches to address triplet repeat disorders such as Huntington’s disease and Myotonic Dystrophy. There are approximately 40 known triple repeat disorders that devastate the lives of people and their families with no known treatment options to date. ...
Triplet Therapeutics Company Profile Office Locations
Triplet Therapeutics is a company that develops biotherapeutic compounds designed to treat repeat expansion disorders. Its biotherapeutics technology provides treatment for repeat expansion disorders including Huntington's disease, myotonic dystrophy, and spinocerebellar ataxias by addressing the underlying cause of the genetic dysfunction that drives disease ...
Triplet Therapeutics Atlas Venture
Triplet Therapeutics is developing transformational treatments for patients with repeat expansion disorders (REDs) – a group of more than 50 known genetic diseases including Huntington’s disease, myotonic dystrophy type 1, spinocerebellar ataxias, fragile X syndrome, and familial amyotrophic lateral sclerosis (ALS) – leveraging insights from the human genetics of REDs.
Nessan Bermingham Chief Ex.. Triplet Therapeutics
(781) 299-7830 HQ Phone (781) 299-7830 Company Triplet Therapeutics Nessan Bermingham Current Workplace Triplet Therapeutics Location One Kendall Square 1400 W, Suite 14201, Cambridge, Massachusetts, 02139, United States Industry Business Services General, Business Services Description Discover more about Triplet Therapeutics
Triplet Therapeutics Overview, News & Competitors
(781) 299-7830 Triplet Therapeutics to Present at Upcoming Events CAMBRIDGE, Mass.--(BUSINESS WIRE)--Triplet Therapeutics, Inc., a biotechnology company leveraging insights from the human genetics of repeat expansion disorders (REDs), today announced that Nessan Bermingham, Ph.D., Triplet’s chief executive officer, president and founder, will present at the following ...
Triplet Therapeutics, Inc. in Cambridge, MA Company Info
Triplet Therapeutics, Inc. is a Massachusetts Foreign Corporation filed On March 18, 2019. The company's File Number is listed as 001374144. The Registered Agent on file for this company is Eugene Kim and is located at One Kendall Sq., Bldg. 200, Ste. 001, Cambridge, MA 02139.
Contact Us Triplet Therapeutics
781-299-7830 Contact Triplet Therapeutics at 781-299-7830 or fill out our contact form to learn more about Triplet Therapeutics.
Triplet Therapeutics LinkedIn
About us. Triplet Therapeutics is a biotechnology company developing transformational treatments for patients with repeat expansion disorders (REDs) -- ...
Triplet Therapeutics
Join Us; Contact; You are now leaving www.triplettx.com, a website provided by Triplet Therapeutics, Inc. The content displayed on external websites is not controlled by Triplet Therapeutics, Inc., and Triplet Therapeutics, Inc. assumes no responsibility for the information or statements on such external websites.
Triplet Therapeutics Employees, Board Members, Advisors
Employee Profiles. Number of Employee Profiles 2. Triplet Therapeutics has 2 current employee profiles, including Founder, CEO & currently Exec Chair Nessan Bermingham. Nessan Bermingham Founder, CEO & currently Exec Chair. Alan J. Buckler Chief Scientific Officer.
Triplet Therapeutics Biotech Careers
Triplet Therapeutics. Website: Triplet Therapeutics. Business Area (s): Therapeutics. Description: Triplet Therapeuticstreatment for repeat expansion disorders — including Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias —.